Search This Blog

Monday, December 11, 2023

Would You Take Out a $200k Loan With No Real Returns for a Decade?

 A hypothetical question for my readers: If I asked you to take out a $200,000 loan to finance a start-up for which you would not see a return for at least a decade, would you take me up on my offer? Keep in mind that you would have to pay interest on this loan while not earning a dime or a dividend from me.

Are you in?

If this deal sounds ludicrous, you're not wrong. Yet, these are precisely the terms required of most students entering medical school today. According to the Association of American Medical Colleges (AAMC), median medical school debt among the class of 2021 was $200,000opens in a new tab or window, not including debt from an undergraduate education. Nearly halfopens in a new tab or window of medical school graduates have at least $150,000 in school debt, and about 15% have more than $300,000.

Like the cost of an undergraduate education, medical school tuition is daunting. In fact, the average cost (tuition, fees, and health insurance) for medical students to attend a public institution in their home state was $38,947opens in a new tab or window during the 2021-2022 school year. Private institution costs totaled more than $61,000 during that academic year.

The soaring cost of medical school education has become a pressing issue not only for aspiring physicians, but also for patients.

Why?

Because it is causing some capable and compassionate individuals to think investment in medical school is not worth itopens in a new tab or window -- even if they believe medicine is their calling. This feeling is compounded by the fact that the average first-year medical resident earns just $60,000opens in a new tab or window a year. While the annual tuition at a top law or business program is about the same as medical school, graduates of those institutions are able to launch their careers sooner and they often command salaries well into the six figures from the start.

The financial burden of medical school also has long-term implications for students' career choices. It pushes them to opt for higher-paying specialties over primary care, for example.

Then there is this problem: Worries about costs are especially burdensome for students from underserved communities. Already, more than ¾ of medical students come from families that were in the top 40%opens in a new tab or window in terms of U.S. household income. A diverse physician workforce is crucial to addressing healthcare disparities and ensuring all patients receive culturally competent care. Over time, high medical school costs will exacerbate existing disparities in access to healthcare.

In fact, we already see evidence that it has kept caring physicians from serving communities in need. In 2019, Tracey Henry, MD, assistant health director at Grady Primary Care Center in Atlanta and an assistant professor of medicine at Emory University School of Medicine, told the U.S. House Small Business Committeeopens in a new tab or window she always dreamed of working with people struggling with homelessness or who lack insurance, but her debt has been a constant worry.

"As much as I love working, giving back to my community through medicine, community service, and training our next generation of doctors, the burden of my student loan debt weighs on me heavily," she said.

We cannot keep asking young physicians to make the choice between feeding their families and serving communities in need. The time has come for state and federal officials to step in to improve medical school affordability. If they do not, the country's physician shortage will only get worse, particularly in rural communities and urban neighborhoods that already qualify as healthcare deserts.

So, what's my prescription for this broken system? Lawmakers should:

  • Increase federal funding for medical education by expanding grants, scholarships, and loan repayment programs that help alleviate the financial burden on medical students and make the field more accessible to individuals from diverse backgrounds.
  • Expand medical school and residency slots in high-need specialties. By increasing the number of available positions, government officials can help meet the growing demand for primary and specialty care physicians in communities with the greatest need.
  • Foster partnerships between medical schools and underserved communities. Encouraging medical schools to develop programs that serve underprivileged communities can help attract students from these areas and contribute to a more diverse physician workforce.
  • Support state initiatives to address the physician shortage. State governments can play a crucial role in expanding medical education opportunities by investing in new medical schools and residency programs, as well as offering incentives for physicians to practice in underserved areas.

Addressing the physician shortage is not only essential for maintaining a high quality of healthcare, but also for ensuring that the needs of an aging and increasingly diverse population are met. The AAMC predicts a shortage of up to 124,000opens in a new tab or window physicians by 2034. Primary care physicians will account for about half of this deficit.

At the same time, doctors are increasingly reportingopens in a new tab or window burnout and depression. Student debt erodesopens in a new tab or window physicians' mental well-being.

In other words: Lawmakers have no time to waste.


N. Adam Brown is a practicing emergency physician, entrepreneur, and healthcare executive. He is the founder of ABIG Health, a healthcare growth strategy firm, and a professor at the University of North Carolina's Kenan-Flagler Business School. 


https://www.medpagetoday.com/opinion/prescriptionsforabrokensystem/107786

'Biden Wants States to Ensure Obamacare Plans Cover Enough Doctors and Hospitals'

 The Biden administration plans to push states to boost oversight of the number of doctors, hospitals, and other health providers insurers cover in Obamacare plans, under rules proposed in November.

The annual regulatory proposal, known as the payment parameters rule, also seeks to expand access to adult dental coverage in Affordable Care Act (ACA) marketplaces and would require states to hold open enrollment periods for Obamacare plans at the same time of year. It's likely one of the last major ACA policy efforts of President Joe Biden's first term -- and, if he loses reelection, could represent his final touches on the landmark health program created when he was vice president.

Biden has been a staunch supporter of Obamacare and has taken stepsopens in a new tab or window during his own first term in the White House to expand the program through rules and legislation, including measures that increased premium subsidiesopens in a new tab or window. In part because of those subsidies, enrollment has increased steadily and hit recordsopens in a new tab or window under his watch.

The proposal for 2025 would continue administration efforts to expand coverage, making it easier for states to offer plans that include adult dental care. The rules also set additional guardrails on the growing number of states that have chosen to run their own ACA marketplacesopens in a new tab or window.

The rules need to be finalized in the spring and would affect plans starting in January 2025, not long before Inauguration Day.

So expect some controversy.

Already, the ACA has entered the political debate, with the current GOP front-runner, former President Donald Trump, taking to his Truth Social site on Thanksgiving weekend to call the failure of the GOP to repeal the ACA "a low point for the Republican Partyopens in a new tab or window."

Trump also said he was "seriously" considering alternatives, which harked back to his presidency when he frequently promisedopens in a new tab or window an Obamacare replacement was soon to be revealed. It never was.

Biden quickly seized on Trump's comments, saying on November 27opens in a new tab or window that "my predecessor has once again -- God love him -- called for cuts that could rip away health insurance for tens of millions of Americans."

Many of the changes made during Biden's term, especially to rules that spell out how the law is to be implemented, could be altered if a Republican wins the White House -- just as occurred in the transition from the Obama administration to the Trump term and, again, when Biden took office.

When Trump came into office, for example, he made a number of moves to roll back ACA rules set by the program's namesake, President Barack Obama, including sharply reducing fundingopens in a new tab or window for enrollment assistance, shortening the annual sign-up periodopens in a new tab or window, and allowing less expensive but less protective short-term plansopens in a new tab or window to cover longer periods of time. Biden's team, in turn, expanded funding for enrollment, added special enrollment periods, and has a proposal awaiting final approval that would restore restrictions on short-term plansopens in a new tab or window, which don't cover many of the benefits included in ACA plans and are often called "junk insurance" by critics.

"If the past is any guide, and the next administration is different, the first thing they will do is roll things back," said Sabrina Corlette, JD, a research professor and co-director of the Center on Health Insurance Reforms at Georgetown University.

Politics may be one reason the administration's latest proposal doesn't include larger changes to the ACA. Doing anything more aggressive in an election year "might disrupt a program that Biden fully supports," said Joseph Antos, PhD, senior fellow at the American Enterprise Institute, a right-leaning think tank.

But the proposal from the Department of Health and Human Services (HHS) does respond to concerns about "network adequacy," or whether insurers' doctor and hospital networks are large enoughopens in a new tab or window to meet demand. The rules would require statesopens in a new tab or window to set numerical standards, such as a maximum "time and distance" that patients must travel to access in-network care, that are at least as rigorous as federal limits that kicked in this year.

The proposal would affect the 18 states, plus the District of Columbia, that run their ownopens in a new tab or window ACA marketplaces.

While many of them already set some network parameters, the standards varyopens in a new tab or window. The administration's latest proposal notes that 25% of existing state rules fail to set any quantitative requirements, such as how long or far a patient might have to drive to find a participating provider, or the acceptable ratio of the number of enrollees in a plan to the number of covered medical providers.

Requiring standards at least as tough as federal exchange rules across all states "would enhance consumer access to quality, affordable care," the document says.

Some states "may not be doing enough to ensure compliance," said Corlette. "States will have to step up their game."

States would also have to review insurer networks to see if they meet the standards before giving the go-ahead to sell their plans. While the federal marketplace will, beginning in 2025, require insurers to meet new rules aimed at limiting patients' wait times for appointments, especially for primary care and behavioral health, state marketplaces won't yet have to impose similar standards.

More prescriptive state requirements for ACA insurers might draw some pushback during the public comment period for the rules, which runs through Jan. 8, 2024. They could also be a target for change if the GOP wins the White House, said Chris Condeluci, JD, a health law attorney who worked as counsel to the Senate Finance Committee when the ACA was drafted.

"On the one hand, it makes sense to have standardized rules so everyone is working off the same song sheet," said Condeluci. But he said there's support for the idea that state marketplaces were not "to be nationally run or overly prescriptive from a federal government regulatory perspective."

The HHS proposal also seeks to expand access to routine adult dental coverage by eliminating a prohibition against states including the care as an "essential health benefit" in their benchmark plansopens in a new tab or window. The rules would also standardize open enrollment periods across all states, requiring them to begin November 1 and run through at least January 15. Most states already do that, although Idaho's period currently begins October 15 and ends December 15, and New York's begins November 16 and ends January 31.

The payment parameter notices, though dryly named, are a big deal not only for insurers, who plan their benefits and set their rates based in part on such rules, but also for consumers.

The ACA marketplaces "cover millions of people and it's very important to make sure they are working and people understand what they are buying," said Bethany Lilly, executive director of public policy at the Leukemia & Lymphoma Society.

https://www.medpagetoday.com/special-reports/features/107743

Walgreens Cut to Junk By Moody’s on Healthcare Strategy Push

  • Walgreens downgraded two notches to second-highest junk rank
  • Downgrade comes as Walgreens pivots to patient-care offerings

Walgreens Boots Alliance Inc. had its senior unsecured credit rating cut to junk by Moody’s Investors Service, with the credit grader citing the drugstore chain’s high debt relative to earnings and risks associated with its push to offer more healthcare services.

The downgrade to Ba2 — two steps into high-yield — reflects “Walgreens’ stubbornly high financial leverage, weak interest coverage and pressured free cash flow that Moody’s believes will be sustained over the next 12-18 months,” senior credit officer Chedly Louis wrote in a note Tuesday.

https://www.bloomberg.com/news/articles/2023-12-11/walgreens-cut-to-junk-by-moody-s-amid-healthcare-strategy-push 

Illumina files registration statement for potential Grail divestiture

 Illumina said on Monday it had filed a registration statement with the U.S. securities regulator related to a potential divestiture of Grail, even as it challenges a European Union order to divest the cancer test maker in court.

Submission of the registration statement "is an important next step in evaluating divestiture options for GRAIL", Illumina said.

Illumina in October said it would divest Grail in 12 months, according to the terms of the European Commission's order, if the life sciences company does not win its challenge in court.

The $7.1 billion deal was opposed by EU antitrust regulators on concerns Illumina would have an incentive to stop Grail's rivals from accessing its technology to develop competing blood-based early cancer detection tests.

https://finance.yahoo.com/news/1-illumina-files-registration-statement-181538403.html

Lilly slumps after disappointing Zepbound weight-loss-drug trial

 Eli Lilly  (LLY)  shares slumped lower Monday after it posted data from a trial of its Zepbound obesity treatment showing patients gained substantial weight when they stopped taking the new drug.

Eli Lilly said patients given regular injections of of trizepatide, which the drugmaker brands as Zepbound, benefited from an average weight loss of around 20.9% from a starting average of around 236.6 pounds over the course of the 36-week study.

However, once the treatment ended and patients were switched to a placebo, they saw an average weight regain of around 14.8% over the following year. Those who continued with the drug lost another 5.5% in weight, according to data from the Surmount-4 study published in the Journal of the American Medical Association.

"Patients, providers and the public do not always understand obesity is a chronic disease that often requires ongoing treatment, which can mean that treatment is stopped once weight goals are met," said Eli Lilly's senior vice president for product development, Jeff Emmick. 

"However, studies like Surmount-4 show that continued therapy can help people living with obesity maintain their weight loss." 

https://www.thestreet.com/investing/stocks/eli-lilly-slumps-after-disappointing-zepbound-weight-loss-drug-trial

Jin Med: RMB66 M in Orders for Innovative Micro-Hyperbaric Oxygen Chamber Equipment

 JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced that it has secured orders of RMB 66 million (approximately $9.18 million USD) of their innovative Micro-Hyperbaric Oxygen Chamber equipment (S-type and M-type) from Conlo Industrial Development (Shanghai) CO., LTD. (“Conlo”).

Building on the successful launches of its MINI micro-hyperbaric oxygen chamber and hydrogen generation machine products in this September, JinMed has recently unveiled S-type (accommodating 2-3 people) and M-type (accommodating 4-6 people) micro-hyperbaric oxygen chambers. Engineered with precision and designed for optimal therapeutic benefits, these chambers are intended to redefine standards in the healthcare industry. Conlo, recognizing the potential of these innovative products, has placed substantial orders totaling RMB 66 million, encompassing 200 units of each chamber type.

Anticipating robust demand, Conlo plans to deploy 10,000 oxygen chambers for human and 10,000 pet oxygen chambers, all of which will be exclusively sourced from JinMed in the Chinese market over the next three years. This strategic collaboration underlines JinMed's commitment to delivering innovative healthcare solutions and meeting the evolving needs of its consumers.

https://www.globenewswire.com/news-release/2023/12/11/2793864/0/en/JIN-MEDICAL-INTERNATIONAL-LTD-Secures-RMB66-Million-in-Orders-for-Innovative-Micro-Hyperbaric-Oxygen-Chamber-Equipment.html

Shale-Drilling Rights Jump to Pre-Covid Price

  • Occidental to pay above $50,000 an acre to CrownRock: Enverus
  • Closely held Endeavor could be next Permian takeover target

 

Drilling rights in the US Permian Basin are commanding prices not seen since the worldwide pandemic crushed oil markets more than four years ago.

Occidental Petroleum Corp.’s $10.8 billion takeover of CrownRock LP equates to more $50,000 per acre for rights to drill some of the richest oil deposits in the hemisphere, according to data-analysis and research firm Enverus Inc. That’s approaching the $60,000 threshold Occidental reached in its blockbuster 2019 deal for Anadarko Petroleum Corp., the biggest deal of Chief Executive Officer Vicki Hollub’s tenure

https://www.bloomberg.com/news/articles/2023-12-11/shale-drilling-rights-jump-to-pre-covid-price-amid-buying-spree